Douglas Joshua
- Hematology top 10%
- Multiple Myeloma Research and Treatments 9
- Platelet Disorders and Treatments 2
-
- Cancer Treatment and Pharmacology 4
- Peptidase Inhibition and Analysis 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 2
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- Ross BrownJohn GibsonJ. N. Alastair GibsonH. KronenbergPaul C. HoDavid GreenJames R. MayDaniel Sze
- Cited by
- HematologyRheumatologyOncology
- Journals
- Cancer (1 paper)British Journal of Haematology (2 papers)The Medical Journal of Australia (1 paper)
- Partner nations
- AustraliaUnited Kingdom
In The Last Decade
Douglas Joshua
14 papers receiving 170 citations
Peers
Comparison fields: 5 of 51
- Hematology 75
- Rheumatology 42
- Oncology 44
- Genetics 15
- Orthopedics and Sports Medicine 12
Countries citing papers authored by Douglas Joshua
This map shows the geographic impact of Douglas Joshua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Joshua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Joshua more than expected).
Fields of papers citing papers by Douglas Joshua
This network shows the impact of papers produced by Douglas Joshua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Joshua. The network helps show where Douglas Joshua may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas Joshua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 6 | |
| 4 | 2012 | 4 | |
| 5 | 2011 | 56 | |
| 6 | 2006 | 16 | |
| 7 | 2005 | 5 | |
| 8 | 2003 | 4 | |
| 9 | 2001 | 5 | |
| 10 | 1994 | 14 | |
| 11 | 1994 | 13 | |
| 12 | 1994 | 13 | |
| 13 | 1989 | 5 | |
| 14 | 1988 | 2 | |
| 15 | 1986 | 19 | |
| 16 | 1984 | 14 |
About Douglas Joshua
Douglas Joshua is a scholar working on Hematology, Oncology and Genetics, having authored 16 papers that have together received 176 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Cancer Treatment and Pharmacology (4 papers), Protein Degradation and Inhibitors (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Platelet Disorders and Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Hematology (75 citations), Rheumatology (42 citations) and Oncology (44 citations). Douglas Joshua has collaborated with scholars based in Australia and United Kingdom. Frequent co-authors include Ross Brown, John Gibson, J. N. Alastair Gibson, H. Kronenberg, Paul C. Ho, David Green, James R. May, Daniel Sze, Shihong Yang and P. Joy Ho. Their work appears in journals such as Cancer, British Journal of Haematology and The Medical Journal of Australia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.